6-((2-((2-((2-((2-aminoethyl)amino)ethyl)amino)ethyl)amino)ethyl)amino)-2-(2-(dimethylamino)ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione

ID: ALA5291106

Max Phase: Preclinical

Molecular Formula: C24H37N7O2

Molecular Weight: 455.61

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)CCN1C(=O)c2cccc3c(NCCNCCNCCNCCN)ccc(c23)C1=O

Standard InChI:  InChI=1S/C24H37N7O2/c1-30(2)16-17-31-23(32)19-5-3-4-18-21(7-6-20(22(18)19)24(31)33)29-15-14-28-13-12-27-11-10-26-9-8-25/h3-7,26-29H,8-17,25H2,1-2H3

Standard InChI Key:  CFGIAFGDDOOICE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 35  0  0  0  0  0  0  0  0999 V2000
    4.3296    1.0710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5046    1.0710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0921    0.3565    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2671    0.3565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8546   -0.3578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0296   -0.3578    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6172   -1.0722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2076   -1.0722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6202   -1.7867    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4451   -1.7867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8556   -1.0714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6803   -1.0714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0946   -1.7825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6840   -2.4998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8593   -2.4998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9193   -1.7825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3334   -2.4936    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3298   -1.0651    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9156   -0.3541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0909   -0.3541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6767    0.3590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8520    0.3590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4415   -0.3582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3262    0.3632    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1545   -1.0651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5670   -1.7796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3920   -1.7796    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8044   -2.4940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8044   -1.0651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7420    1.7854    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5670    1.7854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9795    2.4998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8044    2.4998    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  6  5  1  0
  7  6  1  0
  8  7  1  0
  9  8  1  0
 10  9  1  0
 11 10  1  0
 11 12  2  0
 12 13  1  0
 14 13  2  0
 15 14  1  0
 10 15  2  0
 13 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 20 19  1  0
 12 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 11  1  0
 19 24  2  0
 18 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  1  0
  1 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5291106

    ---

Associated Targets(Human)

HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Calf thymus DNA (4845 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 455.61Molecular Weight (Monoisotopic): 455.3009AlogP: 0.14#Rotatable Bonds: 15
Polar Surface Area: 114.76Molecular Species: BASEHBA: 8HBD: 5
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.66CX LogP: -0.49CX LogD: -5.38
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.19Np Likeness Score: -0.86

References

1. Tomczyk MD, Walczak KZ..  (2018)  l,8-Naphthalimide based DNA intercalators and anticancer agents. A systematic review from 2007 to 2017.,  159  [PMID:30312931] [10.1016/j.ejmech.2018.09.055]

Source